Part 3 of this series for Global Biosimilars Week, penned by Dracey Poore, director of biosimilars at Cardinal Health, ...

The new rules instruct drugmakers to use simple, consumer-friendly language when describing their drugs, without medical ...

For a fifth time this year, the FDA has scolded a pharma company for misleading marketing, this time over a Merz ...

The U.S. Food and Drug Administration (FDA) now requires TV and radio drug ads to be clearer and more direct. The new ...

Clinical development and trial testing of vesleteplirsen (SRP-5051) for Duchenne muscular dystrophy (DMD) was stopped, with ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

The day after the election, some celebrated Trump's win and RFK Jr.'s potential role as a public health decision-maker. Why?

The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...

A disturbance swirling in the Caribbean Sea developed into Tropical Depression Nineteen early Thursday morning. Forecasters ...

Facing with a dialogue with RFK Jr., a top FDA official mounts a public defense of vaccines — and pleads for open minds.

SiPhox Health, with MIT roots, is developing a home blood testing device using a silicon photonic chip, yet to be FDA ...

Vitamin patches are making their way into the main stream, but there's little evidence that they work. Are they worth a try, ...